A great conversation today between the Information Commissioner and the Chair of the Health Research Authority. #RDF2024 A great question on getting anonymisation right, something we thorough endorse - do talk to Simon Pillinger, our Head of Governance who delivered a session exactly this topic yesterday. When asked if he could advocate against the perspective that information governance blocker, the Commissioner said that; 'If you fail to do information governance right then you lose your social license do to research'. Research is built on trust.
Akrivia Health
Biotechnology Research
Oxford, England 3,534 followers
Real world data research, clinical trial optimisation & molecular characterisation for mental health and dementia
About us
With the largest and richest repository of real-world data in neuroscience, Akrivia Health are global leaders in the application of Real World Data for mental health and dementias from HEOR activities through to clinical trial recruitment. Akrivia SynapseTM, our AI driven NLP and data enrichment solution, delivers unprecedented depth in patient characterisation enabling our clients to better understand disease outcome, burden and intervention efficacy, identify potential targets for new molecules, accelerate their clinical trials, and optimise patient outcomes through insights drawn from decades of medical history. Our aim is to enable a new generation of precision neuroscience, to alleviate the burden in one of the world’s most pressing medical needs.
- Website
-
http://www.akriviahealth.com
External link for Akrivia Health
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Oxford, England
- Type
- Privately Held
- Founded
- 2019
Locations
-
Primary
Get directions
Oxford, England OX1 1JH, GB
Employees at Akrivia Health
Updates
-
We had a fabulous time yesterday at The Research and Development Forum, Sophie Gibbons demonstrated the value that Akrivia is providing to the NHS, unlocking data from inaccessible free-text. Out last session will be at 10:40 in Conwy, don't miss it!
-
-
Great to hear from our very own Jessica Venkaya about Akrivia's Research Optimisation Network at The Research and Development Forum #RDF2024
-
-
We are so excited for The Research and Development Forum. Come speak to us in the exhibition hall. Jessica Venkaya will be speaking about clinical trial optimisation, 10:50 in Conwy (up one level from the main auditorium). Sophie Gibbons will giving an overview of Akrivia, 12:30 in Beaumaris. Simon Pillinger will be delivering a fringe session on scalable anonymisation, 13:15 in Beaumaris. See you there! #RDF2024
-
-
Simon Pillinger, our very own Head of Governance will be speaking about #anonymisation at The Research and Development Forum! Monday 13 May, 1@15 in Beaumaris. Link in the comments! Simon will be be covering: -what on earth is anonymisation and why is it useful? -is it possible and what are the challenges? -how to use risk management skills to make an assessment of anonymity against the legal requirements. At the end of the session you'll come away understanding what anonymisation is and how to get there!
-
Thank you Ceyda Uysal for your work into anti-depressant adherence utilising Akrivia Healths real-world data. With our AI-driven NLP models capturing such rich longitudinal data from the EHR, the level of patient characterisation will truly help our life sciences ecosystem positively impact the community.
I am delighted to share I attended the MQ Mental Health Research DataMind Conference 2024 last week, an amazing gathering dedicated to building a health data science enthusiast community. The event provided a platform for exchanging insights and best practices. I found the presentations and discussions with esteemed speakers very insightful! One of the highlights for me was presenting our poster on "Contributors of Antidepressant Non-adherence: A Real-World Study Utilising Electronic Health Records" using Akrivia Health secondary mental healthcare data. With about 280 million people worldwide affected by depressive disorders, addressing medication non-adherence is crucial for enhancing patient outcomes. I'm committed to leveraging data to positively impact mental health, and am excited to continue working on this project! I'm grateful for the invaluable support of my esteemed colleagues, Dr Luke Bryden, Dr Tarso Franarin, our clinical consultants and our outstanding team. Looking forward to working on data-driven projects to improve patient outcomes!
-
-
Panagiota Kontari, PhD presented her incredibly popular poster on psychiatric multimorbidity associated with dementia risk at the UK Datamind conference today. The data Akrivia Health can access is hugely valuable and relevant to understanding the patient trajectory. Thank you Teta for sharing this research with the community
-
-
🔍 Embracing Transparency in Real-World Data 🌐✨ In a captivating episode of Precision Neuroscience Reimagined, Simon Pillinger, Head of Governance, Ethics, and Patient Participation at Akrivia Health, collaborates with Tina to delve into reshaping research dynamics. 🔍 Discover the nuances between anonymised and de-identified data 🔑 Unravel the impact of transparency in reshaping research trajectories. What are your thoughts on enhancing research ethics and transparency? Share your insights below 👇🌟 🎙️ You can find this episode, and the rest of the series wherever you listen to your podcast: https://buff.ly/43Slbd7 All episodes are also available on YouTube! #PrecisionNeuroscienceReimagined #DataTransparency #ResearchEthics #InnovationMatters
-
-
Real World Data (RWD) holds immense potential in Health Economics and Outcomes Research (HEOR)! 🔍 Discover how RWD can revolutionise the field and inform critical aspects of healthcare decision-making. 🌐 https://buff.ly/3PIdU9Q How can RWD help HEOR? 💊 Informing treatment decisions: RWD can provide insights into the effectiveness of various treatment options in real-world settings 💡Assessing cost-effectiveness: RWD can be used to evaluate the cost-effectiveness of healthcare interventions 🎯 Identifying patient populations: RWD can be used to identify patient populations who are most likely to benefit from certain treatments or interventions 🔬 Monitoring Safety: RWD can be used to monitor the safety of healthcare interventions in real-world settings Curious to learn more about the power of RWD in HEOR? #HEOR #RWD #mentalheath #longitudinaldata
LinkedIn
-
Some fascinating insights on multimorbidity developed and presented by the fabulous Panagiota Kontari, PhD at the Translation 2024 DPUK Conference. Using this data will for sure help organisations develop a data driven approach to their drug developments and treatments contact@akriviahealth.com
-